Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Ruth Lupu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5564-3172; OpenAlex author ID A5012328790. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer. Last author DOI 10.1016/j.neo.2025.101143↗
  2. Knock-down of plasminogen-activator inhibitor-1 enhances expression of E-cadherin and promotes epithelial differentiation of human pancreatic adenocarcinoma ce… Co-author DOI 10.1002/jcp.24068↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Travis Vander Steen · 1 shared paper, 2025 · strength 0.22
  2. Robert R. McWilliams · 1 shared paper, 2025 · strength 0.22
  3. Daniel D. Billadeau · 1 shared paper, 2025 · strength 0.22
  4. Liora Segal · 1 shared paper, 2012 · strength 0.03
  5. Monica Lupu‐Meiri · 1 shared paper, 2012 · strength 0.03
  6. Yoram Oron · 1 shared paper, 2012 · strength 0.03
  7. Marvin Carl Gershengorn · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.